Nu Skin Enterprises, Inc.

NYSE:NUS Stock Report

Market Cap: US$375.2m

Nu Skin Enterprises Management

Management criteria checks 3/4

Nu Skin Enterprises' CEO is Ryan Napierski, appointed in Mar 2017, has a tenure of 9.08 years. total yearly compensation is $5.97M, comprised of 16.9% salary and 83.1% bonuses, including company stock and options. directly owns 0.77% of the company’s shares, worth $2.89M. The average tenure of the management team and the board of directors is 8.3 years and 16.3 years respectively.

Key information

Ryan Napierski

Chief executive officer

US$6.0m

Total compensation

CEO salary percentage16.90%
CEO tenure9.1yrs
CEO ownership0.8%
Management average tenure8.3yrs
Board average tenure16.3yrs

Recent management updates

Recent updates

Nu Skin: Patience Is Still Advised

Feb 25

Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk

Jan 17
Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Could Signal Some Risk

Here's Why Nu Skin Enterprises (NYSE:NUS) Has A Meaningful Debt Burden

Oct 12
Here's Why Nu Skin Enterprises (NYSE:NUS) Has A Meaningful Debt Burden

Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Fly 28% But Investors Aren't Buying For Growth

Jul 24
Nu Skin Enterprises, Inc. (NYSE:NUS) Shares Fly 28% But Investors Aren't Buying For Growth

A Look At The Fair Value Of Nu Skin Enterprises, Inc. (NYSE:NUS)

Jul 24
A Look At The Fair Value Of Nu Skin Enterprises, Inc. (NYSE:NUS)

Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

May 30
Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt

Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

May 12
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06

Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Apr 23
Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive

Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Apr 17
Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company

Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?

Mar 25
Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?

Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified

Mar 06
Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified

Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06

Feb 17
Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06

Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load

Feb 15
Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load

Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth

Jan 09

Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns

Dec 21
Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns

Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nov 12
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?

Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation

Nov 12

The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Oct 04
The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%

Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Aug 31
Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business

Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Aug 13
Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price

Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

May 30
Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year

Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

May 13
Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?

Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Mar 28
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal

Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty

Mar 04

We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

Feb 22
We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings

CEO Compensation Analysis

How has Ryan Napierski's remuneration changed compared to Nu Skin Enterprises's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025US$6mUS$1m

US$160m

Sep 30 2025n/an/a

US$110m

Jun 30 2025n/an/a

US$101m

Mar 31 2025n/an/a

-US$39m

Dec 31 2024US$6mUS$1m

-US$147m

Sep 30 2024n/an/a

-US$103m

Jun 30 2024n/an/a

-US$148m

Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$6mUS$992k

US$9m

Sep 30 2023n/an/a

US$59m

Jun 30 2023n/an/a

US$70m

Mar 31 2023n/an/a

US$77m

Dec 31 2022US$5mUS$942k

US$105m

Sep 30 2022n/an/a

US$38m

Jun 30 2022n/an/a

US$113m

Mar 31 2022n/an/a

US$139m

Dec 31 2021US$5mUS$801k

US$147m

Sep 30 2021n/an/a

US$230m

Jun 30 2021n/an/a

US$237m

Mar 31 2021n/an/a

US$219m

Dec 31 2020US$4mUS$721k

US$191m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$146m

Mar 31 2020n/an/a

US$150m

Dec 31 2019US$2mUS$688k

US$174m

Compensation vs Market: Ryan's total compensation ($USD5.97M) is above average for companies of similar size in the US market ($USD2.40M).

Compensation vs Earnings: Ryan's compensation has been consistent with company performance over the past year.


CEO

Ryan Napierski (51 yo)

9.1yrs
Tenure
US$5,965,205
Compensation

Mr. Ryan S. Napierski has been Chief Executive Officer of Nu Skin Enterprises Inc. since September 1, 2021. Mr. Napierski has been the President of Nu Skin Enterprises Inc. since March 7, 2017 and has been...


Leadership Team

NamePositionTenureCompensationOwnership
Steven Lund
Co-Founder & Executive Chairman of the Board30.3yrsUS$748.70k0.24%
$ 909.6k
Ryan Napierski
President9.1yrsUS$5.97m0.77%
$ 2.9m
Chayce Clark
Executive VP4.7yrsUS$2.45m0.26%
$ 975.1k
Justin Keisel
Executive VP & President of Global Sales2.1yrsUS$1.34m0.13%
$ 470.3k
Steven Hatchett
Executive VP & Chief Product Officer8.3yrsUS$1.51m0.23%
$ 855.0k
Blake Roney
Founder42.3yrsUS$621.69kno data
Sandra Tillotson
Founder30.3yrsUS$1.06mno data
Chelsea Lantz
Interim Chief Financial Officerless than a yearno data0.086%
$ 321.2k
Joe Sueper
Senior VP & CTO5.3yrsno datano data
Joseph Chang
Executive VP & Chief Scientific Officer20.2yrsUS$1.12mno data
B.G. Hunt
VP of Treasurerno datano datano data
Marion Shumway
Senior Vice President of Human Resourcesno datano datano data
8.3yrs
Average Tenure
53yo
Average Age

Experienced Management: NUS's management team is seasoned and experienced (8.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Steven Lund
Co-Founder & Executive Chairman of the Board30.3yrsUS$748.70k0.24%
$ 909.6k
Ryan Napierski
President4.8yrsUS$5.97m0.77%
$ 2.9m
Edwina Woodbury
Independent Director10.8yrsUS$271.14k0.047%
$ 177.4k
Daniel Campbell
Lead Independent Director29.1yrsUS$314.36k0.17%
$ 645.5k
Lars Bohlin
Member of Anti-Aging Scientific Advisory Boardno datano datano data
Thomas Pisano
Independent Director17.8yrsUS$250.87k0.15%
$ 550.7k
Zoe Draelos
Member of the Anti-Aging Scientific Advisory Board16.3yrsno datano data
Paul Cox
Member of Anti-Aging Scientific Advisory Boardno datano datano data
Tomas Prolla
Member of Anti-aging Scientific Advisory Board16.5yrsno datano data
Makoto Kuro-O
Member of Anti-Aging Scientific Advisory Boardno datano datano data
Laura Nathanson
Independent Director6.8yrsUS$265.87k0.031%
$ 115.5k
Emma Battle
Independent Director4.8yrsUS$265.87k0.026%
$ 99.2k
16.3yrs
Average Tenure
70yo
Average Age

Experienced Board: NUS's board of directors are seasoned and experienced ( 16.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/10 04:05
End of Day Share Price 2026/04/10 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nu Skin Enterprises, Inc. is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Olivia Tong CheangBofA Global Research
April SceeBTIG
Scott Van WinkleCanaccord Genuity